Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
Organised by the Council on Basic Science: Inspire a new generation of basic cardiovascular science leaders taken from among the most gifted science and medical graduates - Provide opportunities to meet face-to-face role models from an expert faculty of successful cardiovascular scientists.
Mainly early stage researchers (PhD and MD/PhD students in the first three years of their research) plus a few more experienced researchers whose PhD degree was obtained within the last 2 years. Delegate numbers limited to 70.
Giuseppina Caligiuri (FR), Jolanda van der Velden (NL), Jérémy Fauconnier (FR) and Gemma Vilahur (ES) representing the Scientists of Tomorrow
Resources are available by following this link
Sunday 18 June - Novotel Nice Arenas
18:00 Welcome – Course Directors (Chair : Peter Ferdinandy)18:15 Opening keynote plenary lecture Jörg Menche (Vienna - Austria) Network modelling and analysis in cardiovascular disease19:15 Cocktail dinner
Session 1: Cardioprotection (Chair : Jeremy Fauconnier)09:00 Key pathways to ischemia-reperfusion injury - Sean Davidson (London - United Kingdom)09:45 Opportunities and challenges in translating cardioprotection to the clinic Gemma Vilahur (Barcelona - Spain)10:30 Coffee break – poster areaSession 2: Cardiac and vascular development (Chair : Giuseppina Caliguri)11:00 Cardiac development: insights into congenital heart disease Adriana Gittenburger-de Groot (Leiden, Netherlands) 11.45 Origins of vascular smooth muscle cells and implications for disease Sanjay Sinha (Cambridge, United Kingdom)12:30 Lunch Boxes – Poster Area- Meet the faculty
Session 3: Thrombosis and coagulation (Chair : Jeremy Pearson)13:30 Control of thrombosis and fibrinolysis in vivo: implications for new therapies Nicola Mutch (Aberdeen, United Kingdom) 14:15 Novel oral anticoagulants: mechanisms of action and therapeutic indications Raffaele de Caterina (Chieti, Italy)15:00 Short breakSession 4: Publishing your research (Chair : Peter Ferdinandy)15.15 Getting the experimental design and statistical analysis right Dirk Duncker (Rotterdam, Netherlands)16.00 Writing the paper: what the journal editors expect Karin Sipido (Leuven, Belgium; Editor in Chief, Cardiovascular Research)17.00 Refreshments - Poster area – Meet the faculty and exhibitors
Session 5: Novel methods to measure and control cardiomyocyte function (Chair: Jolanda van der Velden)09.00 Measuring the physiological responses of single cardiomyocytes Michiel Helmes (Ionoptix) 09.45 Optogenetic control of cardiac rhythm Claudia Richter (Göttingen, Germany) 10.30 Coffee Break – poster areaSession 6: The immune response and atherogenesis (Chair : Jeremy Pearson)11.00 The roles of T and B cells Giuseppina Caligiuri (Paris, France) 11.45 Targeting immune receptors to reduce atherosclerosis Norbert Gerdes (Düsseldorf, Germany)12.30 Lunch Boxes – Poster area - Meet the facultySession 7: Regenerative medicine (Chair : Gemma Vilahur)13.30 Therapeutic angiogenesis: the long road to translation Seppo Ylä-Herttuala (Kuopio, Finland) 14.15 Bioengineered grafts for the infarcted heart Antoni Bayés Genis (Barcelona, Spain)15.00 Short breakSession 8: How and why pharma and academia collaborate to develop new medicines (Chair: Jeremy Fauconnier)15.15 Role of academic research and spin-off (start-up) companies in drug development Peter Ferdinandy (Budapest, Hungary)15.50 How Big Pharma and academia collaborate Patricia Sansilvestri-Morel (Suresnes, France)16.20 Development of advanced therapy medicinal products: need for collaborations with academia and specialized R&D companies Swetlana Adamsky (Tel-Aviv, Israel)16:50 Short Break17.00 Poster area – discussion of even-numbered posters, with refreshments
Session 9: Cardiac contractile dysfunction (Chair : Jolanda van der Velden)09.00 Cardiometabolic dysregulation, mitochondrial function and arrhythmia Jérémy Fauconnier (Montpellier, France) 09.45 Cardiomyopathies: biology and future treatment options Jolanda van der Velden (Amsterdam, Netherlands)10.30 Coffee Break – poster areaSession 10: Non-coding RNAs (Chair : Giuseppina Caliguri)11:00 Control of cardiac remodelling and fibrosis by ncRNAs Paula da Costa Martins (Maastricht, Netherlands) 11:45 Control of angiogenesis and arteriogenesis by miRNAs Yaël Nossent (Leiden, Netherlands) 12:30 Lunch Boxes – Poster area - Meet the faculty
Session 11: Vulnerable Plaque ( Chair: jeremy Perason)13:30 The vulnerable plaque – an evolving target? Gerard Pasterkamp (Utrecht, Netherlands)14:15 Imaging the vulnerable plaque to stratify individual patient risk Marc Dweck (Edinburgh, United Kingdom)15:00 Short break Session 12: Finding new drug targets: the worlds of informatics and omics (Chair : Peter Ferdinandy)15.15 The advantages and limitations of proteomics and metabolomics Manuel Mayr (London, United Kingdom)15.45 Using Mendelian randomization to impute causality in genomic studies Jemma Hopewell (Oxford, United Kingdom)17.00 Poster area – discussion of odd-numbered posters, with refreshments20.30 Participants dinner (Beach party!)
Session 13: Building your career 09.00 Advice from Professor Jeremy Pearson and open discussion10.00 Coffee Break
Session 14: iPS cells and personalised medicine (Chair : Gemma Vilahur)10.30 iPS cell-derived cardiomyocytes for drug testing Daniel Sinnecker (Munich, Germany)11.15 iPS cell-derived cardiomyocytes: directing phenotype for therapeutic use Chris George (Swansea, United Kingdom) 12.00 Closing keynote plenary lecture (Chair : Jeremy Pearson) Healthy cardiovascular aging: the life course perspective Mark Hanson (Southampton, United Kingdom)
Discover more about the ESC Council on Basic Cardiovascular Science
The Summer School 2017 has a limited number of places. If you are accepted, your registration will be considered when payment of 300 Euros is made to the ESC.
The European Heart House Les Templiers2035 Routes des CollesCS 80179 Biot06903 Sophia Antipolis Cedex, France
Jeremy Pearson (UK)
Peter Ferdinandy (HU)
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 BIOT
06903 Sophia Antipolis, FR
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved